↓ Skip to main content

Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?

Overview of attention for article published in Frontiers in oncology, August 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
1 news outlet
twitter
3 X users

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
78 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?
Published in
Frontiers in oncology, August 2019
DOI 10.3389/fonc.2019.00689
Pubmed ID
Authors

Ilaria Del Giudice, Sara Raponi, Irene Della Starza, Maria Stefania De Propris, Marzia Cavalli, Lucia Anna De Novi, Luca Vincenzo Cappelli, Caterina Ilari, Luciana Cafforio, Anna Guarini, Robin Foà

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 78 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 18%
Other 8 10%
Student > Ph. D. Student 7 9%
Student > Postgraduate 5 6%
Student > Bachelor 5 6%
Other 14 18%
Unknown 25 32%
Readers by discipline Count As %
Medicine and Dentistry 20 26%
Biochemistry, Genetics and Molecular Biology 15 19%
Engineering 2 3%
Agricultural and Biological Sciences 1 1%
Immunology and Microbiology 1 1%
Other 8 10%
Unknown 31 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2021.
All research outputs
#3,345,307
of 25,385,509 outputs
Outputs from Frontiers in oncology
#970
of 22,432 outputs
Outputs of similar age
#65,307
of 350,078 outputs
Outputs of similar age from Frontiers in oncology
#35
of 356 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,432 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 350,078 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 356 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.